Research Study to Investigate How Well Semaglutide Works in People Living With Heart Failure and Obesity

NCT04788511 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

529

Enrollment

INDUSTRY

Sponsor class

Conditions

Obesity

Interventions

DRUG: Semaglutide
DRUG: Placebo (semaglutide)

Sponsor

Novo Nordisk A/S